Oxidative damage–induced inflammation initiates age-related macular degeneration

Oxidative damage and inflammation are postulated to be involved in age-related macular degeneration (AMD). However, the molecular signal(s) linking oxidation to inflammation in this late-onset disease is unknown. Here we describe AMD-like lesions in mice after immunization with mouse serum albumin adducted with carboxyethylpyrrole, a unique oxidation fragment of docosahexaenoic acid that has previously been found adducting proteins in drusen from AMD donor eye tissues and in plasma samples from individuals with AMD. Immunized mice develop antibodies to this hapten, fix complement component-3 in Bruch's membrane, accumulate drusen below the retinal pigment epithelium during aging, and develop lesions in the retinal pigment epithelium mimicking geographic atrophy, the blinding end-stage condition characteristic of the dry form of AMD. We hypothesize that these mice are sensitized to the generation of carboxyethylpyrrole adducts in the outer retina, where docosahexaenoic acid is abundant and conditions for oxidative damage are permissive. This new model provides a platform for dissecting the molecular pathology of oxidative damage in the outer retina and the immune response contributing to AMD.

[1]  M. Miyagi,et al.  Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration* , 2003, Journal of Biological Chemistry.

[2]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. V. Johnson,et al.  A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.

[4]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[5]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[6]  S. Fliesler,et al.  Chemistry and metabolism of lipids in the vertebrate retina. , 1983, Progress in lipid research.

[7]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[9]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[10]  M. Matthes,et al.  Lipids of bovine retinal pigment epithelium. , 1976, Experimental eye research.

[11]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[12]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[13]  M Peakman,et al.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal? , 1989, Journal of clinical pathology.

[14]  J. Seddon,et al.  Do age-related macular degeneration and cardiovascular disease share common antecedents? , 1999, Ophthalmic epidemiology.

[15]  R. Anderson,et al.  Lipids of ocular tissues. IV. A comparison of the phospholipids from the retina of six mammalian species. , 1970, Experimental Eye Research.

[16]  W. Green,et al.  Light-induced deposits in Bruch's membrane of protoporphyric mice. , 1993, Archives of ophthalmology.

[17]  T. Shinohara,et al.  Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. , 1990, Journal of immunology.

[18]  M. Belkin,et al.  The association between cigarette smoking and ocular diseases. , 1998, Survey of ophthalmology.

[19]  Eiji Sakurai,et al.  An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.

[20]  G. Malek,et al.  Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R J Glynn,et al.  A prospective study of cigarette smoking and risk of age-related macular degeneration in men. , 1996, JAMA.

[22]  R. Willke,et al.  Incidence of exudative age-related macular degeneration among elderly Americans. , 2003, Ophthalmology.

[23]  Scott W Cousins,et al.  The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. , 2002, Experimental eye research.

[24]  W. Willett,et al.  A prospective study of cigarette smoking and age-related macular degeneration in women. , 1996, Journal of the American Medical Association (JAMA).

[25]  S. Hazen,et al.  Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and Peptide adduction chemistry. , 2003, The Journal of organic chemistry.

[26]  Robert F. Mullins,et al.  An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[27]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[28]  Usha Chakravarthy,et al.  Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). , 2006, Archives of ophthalmology.